Erratum to: Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation

Abdullah Al-Dhfyan^{1

2}, Ali Alhoshani¹, Hesham M Korashy³

Affiliations

¹ Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 11451, Saudi Arabia.
² Stem Cell & Tissue Re-Engineering, King Faisal Specialist Hospital and Research Center, Riyadh, 11211, Saudi Arabia.
³ Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 11451, Saudi Arabia. hkorashy@ksu.edu.sa.

Published Erratum

Abdullah Al-Dhfyan et al. Mol Cancer. 2017.

. 2017 Mar 24;16(1):69.

doi: 10.1186/s12943-017-0636-5.

Abdullah Al-Dhfyan^{1

2}, Ali Alhoshani¹, Hesham M Korashy³

¹ Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 11451, Saudi Arabia.
² Stem Cell & Tissue Re-Engineering, King Faisal Specialist Hospital and Research Center, Riyadh, 11211, Saudi Arabia.
³ Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 11451, Saudi Arabia. hkorashy@ksu.edu.sa.

No abstract available

Erratum for

Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A, Alhoshani A, Korashy HM. Al-Dhfyan A, et al. Mol Cancer. 2017 Jan 19;16(1):14. doi: 10.1186/s12943-016-0570-y. Mol Cancer. 2017. PMID: 28103884 Free PMC article.

1. Al-Dhfyan A, Alhoshani A, Korashy HM. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation. Mol Cancer. 2017;16:14. doi: 10.1186/s12943-016-0570-y. - DOI - PMC - PubMed